NicOx
Nicox is an ophthalmology company that develops therapeutics designed to maintain vision and improve ocular health. The company utilizes nitric oxide donation technology to create treatments for eye diseases, including its lead drug candidate NCX 470 for glaucoma. Its business model involves advancing clinical-stage assets toward regulatory submission and commercialization through strategic partnerships.
Visit websiteFrance
Biotechnology
Ophthalmology
Healthcare
Funding summary
- Total raised
- €26.3M
- Funding rounds
- 1
Investors in NicOx
Investors on record for NicOx. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like NicOx?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors